Evaluation of the effect of para-sternal block on postoperative respiratory function after cardiac sternotomy surgery. Prospective, controlled, randomized, single-blind study with independent evaluation of the judgment criterion

Evaluation of the effect of para-sternal block on postoperative respiratory function after cardiac sternotomy surgery. Prospective, controlled, randomized, single-blind study with independent evaluation of the judgment criterion - PARACARD

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2022-000833-18-FR

Enrollment

Unknown

Registered

2022-03-22

Start date

2022-05-03

Completion date

Unknown

Last updated

2024-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pulmonary complications post cardiac surgery

Interventions

Trade Name: ROPIVACAINE Pharmaceutical Form: Solution for injection in vial INN or Proposed INN: ROPIVACAINE CAS Number: 84057-95-4

Eligibility

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) no F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Main Objective: ;Secondary Objective: ;Primary end point(s): ;Timepoint(s) of evaluation of this end point: D1 post op	—

Secondary

Measure	Time frame
Timepoint(s) of evaluation of this end point: Several depending o the endoint	—

Countries

France

Contacts

Public ContactBoussault A.

CHU Amiens Picardie

boussault.annabelle@chu-amiens.fr33322 08 83 69369

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026